Talon Therapeutics, Inc. (HNAB)' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012
2/3/2012
More...
|
Molecular Insight Pharmaceuticals, Inc. (MIPI) Presents Human Data Demonstrating Detection of Metastatic Prostate Cancer
2/3/2012
More...
|
Positive Data Presented on Athersys, Inc.' MultiStem to Treat Stroke
2/3/2012
More...
|
Exelixis, Inc. (EXEL) Release: Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma
2/3/2012
More...
|
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology
2/3/2012
More...
|
Acorda Therapeutics (ACOR) Presents Preclinical Data Showing Dalfampridine Improves Motor Function in Chronic Stroke
2/3/2012
More...
|
American Stroke Association Release: New Drug Doesn't Improve Disability Among Stroke Patients
2/3/2012
More...
|
American Stroke Association Release: Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk of Bleeding, Death
2/3/2012
More...
|
American Stroke Association Release: Warfarin and Aspirin are Similar in Heart Failure Treatment
2/3/2012
More...
|
ISCTM Pushes for Innovation in the Development of Novel Therapies for CNS Disorders
2/3/2012
More...
|
Covidien (COV) Release: Results from Solitaire with the Intention for Thrombectomy (SWIFT) Study Announced at the International Stroke Conference on February 3
2/3/2012
More...
|
Diamyd Medical AB's Phase III Study Published in The New England Journal of Medicine
2/2/2012
More...
|
StemCells Inc. (STEM) Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
2/2/2012
More...
|
Cannabis Science Inc. Reports Success for 4th Brand New Self-Administering Cancer Patient
2/2/2012
More...
|
Compugen Ltd. (CGEN) Cancer Target Results Demonstrate Significant Potential for Cancer Immunotherapy
2/2/2012
More...
|